Table 1.
Clinical characteristics of patients enrolled in CARVIDA study (n=99)
| Parameter | Value |
|---|---|
| Age, yr, median (range) | 65 (23–78) |
| Sex, men/women | 57/42 |
| Weight, kg, mean±SD | 85±17 |
| Height, cm, mean±SD | 172±9 |
| Body mass index, kg/m2, median (range) | 28 (18–41) |
| Office SBP, mmHg, mean±SD | 133±15 |
| Office DBP, mmHg, mean±SD | 81±10 |
| 24-h SBP, mmHg, mean±SD | 126±11 |
| 24-h DBP, mmHg, mean±SD | 77±8 |
| Hypertension, % | 92 |
| Treatment resistant hypertension, % | 14 |
| Number of BP medications, median (range) | 2 (0–6) |
| ACE inhibitor, % | 32 |
| ARB, % | 44 |
| β Blocker, % | 35 |
| Calcium channel antagonist, % | 38 |
| Diuretic, % | 49 |
| Thiazide diuretic, % | 27 |
| Loop diuretic, % | 22 |
| Aldosterone antagonist, % | 7 |
| Diabetes mellitus, % | 28 |
| Coronary artery disease, % | 8 |
| Cerebrovascular disease, % | 7 |
| Peripheral vascular disease, % | 3 |
| Diabetic nephropathy, % | 19 |
| Vascular nephropathy, % | 28 |
| Systemic disease affecting the kidney, % | 16 |
| Primary glomerulopathy, % | 23 |
| Serum creatinine, mg/dl, median (range) | 1.3 (0.6–4.3) |
| eGFR, ml/min per 1.73 m2, median (range) | 51 (13–127) |
| UACR, mg/g creatinine, median (range) | 432 (1–2670) |
SBP, systolic blood pressure; DBP, diastolic blood pressure; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blockers; eGFR, estimated glomerular filtration rate; UACR, urinary albumin-to-creatinine ratio.